Solid tumor (phase I)
Clinical trials for Solid tumor (phase I) explained in plain language.
Never miss a new study
Get alerted when new Solid tumor (phase I) trials appear
Sign up with your email to follow new studies for Solid tumor (phase I), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a Two-Pronged drug attack Hard-to-Treat tumors?
Disease control Not yet recruitingThis first-in-human trial tests an experimental drug called BD200 in adults with advanced solid tumors that have not responded to standard treatments. BD200 is designed to latch onto two proteins, Trop-2 and Nectin-4, found on many cancer cells, potentially delivering a toxic pay…
Matched conditions: SOLID TUMOR (PHASE I)
Phase 1 • Sponsor: Biolojic Design Ltd. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Smart drug targets two cancer weaknesses at once
Disease control Not yet recruitingThis trial tests a new drug called AN4035 in people with advanced solid tumors that have RAS mutations and high levels of the CEACAM5 protein. The drug is designed to seek out cancer cells carrying CEACAM5 and deliver a payload that blocks RAS, a key driver of cancer growth. The …
Matched conditions: SOLID TUMOR (PHASE I)
Phase 1 • Sponsor: Adlai Nortye Biopharma Co., Ltd. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC